SCHEMBL7486541

SCHEMBL7486541

COc1ccc(N2C[C@H](CN3CCC(Cc4ccc(NC(C)=O)cc4)CC3)OC2=O)cc1

nearest known ligand 0.55

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 16/20 0.55
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
CCR3 P51677 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7487717 0.89 F10 (0.51) SIGMAR1SMN1; SMN2
SCHEMBL7484050 0.89 CCR3 (0.49) SIGMAR1CCR3
SCHEMBL7487233 0.89 GRM2 (0.50) SIGMAR1SMN1; SMN2
SCHEMBL8798977 0.88 SIGMAR1 (0.57) SIGMAR1
SCHEMBL8799808 0.88 SIGMAR1 (0.57) SIGMAR1
SCHEMBL8798693 0.88 SIGMAR1 (0.57) SIGMAR1
SCHEMBL7484241 0.86 SIGMAR1 (0.59) SIGMAR1
SCHEMBL7473692 0.85 SIGMAR1 (0.66) SIGMAR1CCR3
SCHEMBL8799161 0.85 SIGMAR1 (0.54) SIGMAR1
SCHEMBL9678853 0.85 SIGMAR1 (0.65) SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0763535-B1 Piperidinylmethyloxazolidin-2-one derivatives, their preparation and their use as pharmacological active CNS compounds MERCK PATENT GMBH (DE) 2002-11-27 EP claimed
EP-0763535-A1 Piperidinylmethyloxazolidin-2-one derivatives, their preparation and their use as pharmacological active CNS compounds MERCK PATENT GmbH (DE) 1997-03-19 EP claimed
EP-0763535-B1 Piperidinylmethyloxazolidin-2-one derivatives, their preparation and their use as pharmacological active CNS compounds MERCK PATENT GMBH (DE) 2002-11-27 EP disclosed
EP-0763535-A1 Piperidinylmethyloxazolidin-2-one derivatives, their preparation and their use as pharmacological active CNS compounds MERCK PATENT GmbH (DE) 1997-03-19 EP disclosed